ATE204296T1 - Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin - Google Patents

Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin

Info

Publication number
ATE204296T1
ATE204296T1 AT94920616T AT94920616T ATE204296T1 AT E204296 T1 ATE204296 T1 AT E204296T1 AT 94920616 T AT94920616 T AT 94920616T AT 94920616 T AT94920616 T AT 94920616T AT E204296 T1 ATE204296 T1 AT E204296T1
Authority
AT
Austria
Prior art keywords
arginine vasopressin
ddavp
gln
cys
asn
Prior art date
Application number
AT94920616T
Other languages
English (en)
Inventor
Bo Ake Krister Larsson
Thomas Bjoern Mellbrand
Ewa Maria Birgitta Moernstam
Jan Anders Ingemar Roschester
Jan-Ake Skoeldbaeck
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of ATE204296T1 publication Critical patent/ATE204296T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT94920616T 1993-06-29 1994-06-22 Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin ATE204296T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/084,847 US5500413A (en) 1993-06-29 1993-06-29 Process for manufacture of 1-deamino-8-D-arginine vasopressin
PCT/SE1994/000621 WO1995001373A1 (en) 1993-06-29 1994-06-22 Process for manufacture of 1-deamino-8-d-arginine vasopressin

Publications (1)

Publication Number Publication Date
ATE204296T1 true ATE204296T1 (de) 2001-09-15

Family

ID=22187597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920616T ATE204296T1 (de) 1993-06-29 1994-06-22 Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin

Country Status (14)

Country Link
US (1) US5500413A (de)
EP (1) EP0710247B1 (de)
JP (1) JP3453144B2 (de)
KR (1) KR0163224B1 (de)
CN (1) CN1040648C (de)
AT (1) ATE204296T1 (de)
CA (1) CA2166297C (de)
DE (1) DE69427985T2 (de)
DK (1) DK0710247T3 (de)
ES (1) ES2159562T3 (de)
GR (1) GR3036935T3 (de)
HK (1) HK1000910A1 (de)
PT (1) PT710247E (de)
WO (1) WO1995001373A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
PT710243E (pt) * 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP2316468A1 (de) 2002-02-22 2011-05-04 Shire LLC Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2004092202A1 (en) * 2003-04-07 2004-10-28 Novetide, Ltd. Process for production of cyclic peptides
EP2322195A2 (de) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
EP1530967B1 (de) * 2003-11-13 2006-05-03 Ferring B.V. Blisterverpackung und feste Dosierungsform enthaltend Desmopressin
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PL2712622T3 (pl) * 2008-05-21 2017-01-31 Ferring B.V. Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
ES2638815T5 (en) * 2009-06-18 2025-06-26 Acerus Pharmaceuticals Usa Llc Safe desmopressin administration
JO3371B1 (ar) * 2013-07-26 2019-03-13 Ferring Bv ناهضات مستقبل فاسوبريسين 2

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
ZA733419B (en) * 1972-07-04 1974-03-27 Hoffmann La Roche Nonapeptides and process for the preparation thereof
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides

Also Published As

Publication number Publication date
DE69427985D1 (de) 2001-09-20
DK0710247T3 (da) 2001-10-01
CA2166297C (en) 2001-03-27
DE69427985T2 (de) 2002-03-28
GR3036935T3 (en) 2002-01-31
US5500413A (en) 1996-03-19
ES2159562T3 (es) 2001-10-16
EP0710247B1 (de) 2001-08-16
CN1040648C (zh) 1998-11-11
CN1125952A (zh) 1996-07-03
KR960703411A (ko) 1996-08-17
PT710247E (pt) 2001-12-28
HK1000910A1 (en) 2002-03-15
WO1995001373A1 (en) 1995-01-12
CA2166297A1 (en) 1995-01-12
JP3453144B2 (ja) 2003-10-06
EP0710247A1 (de) 1996-05-08
KR0163224B1 (ko) 1998-11-16
JPH09502423A (ja) 1997-03-11

Similar Documents

Publication Publication Date Title
ATE204296T1 (de) Verfahren zur herstellung von 1-desamino-8-d- arginin-vasopressin
IE901673L (en) Enzymatic removal of a protein amino-terminal sequence
EP0991660B8 (de) DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
EP0233838A3 (de) Neuriten stimulierender Faktor und Prozess für seine Herstellung
DK1396542T3 (da) P-selectin ligand protein
ATE224912T1 (de) Verfahren zur herstellung von peptiden
EP0927756A4 (de) Proteine mit zellulase-aktivitäten und prozess für ihre herstellung
DE3687006D1 (de) Verfahren zur herstellung von 2-alkoxy-n-(1-azabicyclo(2.2.2)octan-3-yl)aminobenzamiden.
ES488382A1 (es) Procedimiento para la preparacion de lh-rh o de analogos de lh-rh
ATE99662T1 (de) Verfahren zur herstellung von 1,1-dichlor-1fluorethan.
DE3380819D1 (en) A precursor of a c-terminal amidated peptide and production thereof
CA2011378A1 (en) Achromobacter protease i gene and gene product thereof
DE59813491D1 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
AU1141592A (en) Curculin b and dna encoding same, and process for production thereof
PT73587A (en) Process for preparing novel peptides
EP0106282A3 (de) Herstellung einer Caerulein-Zwischenverbindung
ES8505939A1 (es) Procedimiento para preparar compuestos que contienen grupos amida de acido carboxilico
JPS6483058A (en) Novel tripeptide compound
EP0625580A4 (en) Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient.
JPS6460391A (en) Production of gamma-halo-beta(r)-hydroxybutyric acid ester
ATE33854T1 (de) Verfahren zur biotechnischen herstellung von l|pfels|ure.
TW243453B (en) Cloning and characterization of a cardiac adenylyl cyclase
HUT40993A (en) Process for production of esthers of o /2,6-dichlorphenilamino/-phenil-acetic acid
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES
CA2141456A1 (en) A process for the preparation of (-)-eserethole from mixtures of (-) and (+)-eserethole